1. Homepage
  2. Equities
  3. Saudi Arabia
  4. Saudi Arabian Stock Exchange
  5. Dr. Sulaiman Al Habib Medical Services Group Company
  6. Summary
    4013   SA1510P1UMH1

DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY

(4013)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Saudi Arabian Stock Excha…
05/12/2022 05/15/2022 05/16/2022 05/17/2022 05/18/2022 Date
195.2 203.4 213 214 213.8 Last
270137 292508 1034417 445843 333532 Volume
-3.94% +4.20% +4.72% +0.47% -0.09% Change
Estimated financial data (e)
Sales 2022 7 979 M 2 127 M 2 127 M
Net income 2022 1 568 M 418 M 418 M
Net Debt 2022 863 M 230 M 230 M
P/E ratio 2022 47,6x
Yield 2022 1,42%
Sales 2023 8 934 M 2 382 M 2 382 M
Net income 2023 1 633 M 435 M 435 M
Net Debt 2023 1 540 M 410 M 410 M
P/E ratio 2023 45,7x
Yield 2023 1,39%
Capitalization 74 830 M 19 949 M 19 949 M
EV / Sales 2022 9,49x
EV / Sales 2023 8,55x
Nbr of Employees -
Free-Float 26,2%
More Financials
Company
Dr. Sulaiman Al-Habib Medical Services Group Company is a Saudi Arabia-based company engaged in health care sector. The Company operates through it's subsidiaries in three segments: Hospitals, Pharmacies and Other. The Hospital segment is engaged in setting up, managing and operating hospitals, medical facilities, pharmacies and medical diagnostic and radiological laboratories. The Pharmacies segment operates Al... 
More about the company
Ratings of Dr. Sulaiman Al Habib Medical Services Group Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY
04/24Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the F..
CI
04/24Dr. Sulaiman Al Habib Medical Services Group Company Recommends to Distribute Cash Divi..
CI
03/24Dr. Sulaiman Al Habib Medical Services Group Company entered into an agreement to acqui..
CI
02/23Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the F..
CI
02/19Dr. Sulaiman Al Habib Medical Services Group Recommends Cash Dividend for the Fourth Qu..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Company Announces Management Appointments
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces Signing Lease Contract Sign Off ..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces Contract Sign Off by Its Subsidi..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces Contract Sign Off by Its Subsidi..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces the Board Approval of Its Strate..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the T..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces the Distribution of Cash Dividen..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces Contract Sign Off by its Subsidi..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the S..
CI
2021Dr. Sulaiman Al Habib Medical Services Group Announces Distribution for Second Quarter ..
CI
More news
News in other languages on DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY
04/24La société Dr. Sulaiman Al Habib Medical Services Group Company annonce les résultats d..
04/24La société Dr. Sulaiman Al Habib Medical Services Group recommande de distribuer un div..
02/23La société Dr. Sulaiman Al Habib Medical Services Group Company annonce ses résultats p..
02/19Le groupe de services médicaux Dr. Sulaiman Al Habib recommande le versement d'un divid..
2021Le groupe Dr. Sulaiman Al Habib Medical Services annonce la distribution d'un dividende..
More news
Chart DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY
Duration : Period :
Dr. Sulaiman Al Habib Medical Services Group Company Technical Analysis Chart | 4013 | SA1510P1UMH1 | MarketScreener
Technical analysis trends DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Last Close Price 213,80 SAR
Average target price 172,39 SAR
Spread / Average Target -19,4%
EPS Revisions
Managers and Directors
Nasser Mohammad Abdulaziz Al-Huqbani Chief Executive Officer & Executive Director
Faisal Abdullah Ali Al Nassar Chief Financial Officer & Executive Director
Sulaiman bin Abdulaziz Al-Habib Chairman
Abdul Wahab Abdullah Mohammad Al Abdul Wahab Chief Operating Officer
Mazen Abdulrazzaq Sulaiman Al-Rumaih Vice Chairman